(Q44038477)

29 November 2017

Terbinafine hepatotoxicity resulting in chronic biliary ductopenia and portal fibrosis (English)

1 reference

29 November 2017

0 references

1 reference

Frank A Anania

1

1 reference

PubMed ID

12079721

29 November 2017

Lionel Rabin

series ordinal

2

1 reference

PubMed ID

12079721

29 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

American Journal of Medicine

29 November 2017

1 reference

29 November 2017

112

1 reference

29 November 2017

9

1 reference

29 November 2017

741-742

1 reference

Oral antifungal agents for onychomycosis

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901109-9

Terbinafine-associated hepatic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901109-9

Terbinafine-induced cholestatic liver disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901109-9

Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901109-9

Carbon monoxide poisoning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901109-9

A randomized treatment duration-finding study of terbinafine in onychomycosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901109-9

10.1016/S0002-9343(02)01109-9

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference

PubMed ID

12079721